PerTabFig.md

Tuberculosis in the Philippines: analysis of case notification data in 2013

1. Introduction

---

2. Accomplishment (Drug susceptible)

---

a. Case notification for all TB cases -2000 to 2013

i. National - by type of TB cases (new smear positive, new smear negative, EP, relapse and re-treatment cases) annually

ii. Regional - y type of TB cases (new smear positive, new smear negative, EP, relapse and re-treatment cases) annually

## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?

b. Case notification for new smear positive by age and sex annually

i. National

ii. Regional

## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?

c. Casefinding

i. National - Number of TB symptomatics examined by smear microscopy by year

ii. Regional - Number of TB symptomatics examined by smear microscopy by year

(Should this be per population to make it comparable?)

## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?
## geom_path: Each group consist of only one observation. Do you need to adjust the group aesthetic?

iii. Summary of laboratory activities per year per region

1. Number of TB symptomatics examined
2. Number with three sputum specimens
3. Number of smear positive
4. Positivity rate

d. Caseholding

i. National

1. New smear positive
2. New smear negative
3. Relapse + Failure + RAD

ii. National

1. New smear positive

2. New smear negative

3. Relapse + Failure + RAD

4. Accomplishment (Drug resistant) 2000 to 2013

---

a. Casefinding

i. National

b. Caseholding

i. National

4. Accomplishment � Children

---

5. Accomplishment � PPMD

---

6. Accomplishment � Jails and Prisons

---

7. Accomplishment � TB/HIV

---

8. Policies

---

9. Budget

---

10. Partners

---